Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
DETECTION OF NEURODEGENERATIVE DISEASES
Document Type and Number:
WIPO Patent Application WO/2017/153922
Kind Code:
A3
Abstract:
The present invention relates to novel compounds, their uses as biomarker, and/or methods including a non-invasive in vitro method using this biomarker, for diagnosing or monitoring the development or the progression of Alzheimer's disease (AD) or a disease or disorder associated with β-amyloid peptide (Aβ) deposition or tau hyperphosphorylation or a disease or disorder characterized by a proteinopathy implicating abnormalities in protein kinase C (PKC).

Inventors:
MOUSSAOUI SALIHA (FR)
WILDEMANN DIRK (DE)
WENSCHUH HOLGER (DE)
SCHNATBAUM KARSTEN (DE)
ULRICH GILLES (FR)
DE BARRY JEAN (FR)
MBEBI-LIEGEOIS CORINNE (FR)
FIRAT HUESEYIN (FR)
Application Number:
PCT/IB2017/051343
Publication Date:
October 19, 2017
Filing Date:
March 07, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
AMONETA DIAGNOSTICS SAS (FR)
JPT PEPTIDE TECH GMBH (DE)
CNRS - CENTRE NAT DE LA RECH SCIENT (FR)
UNIV STRASBOURG (FR)
International Classes:
C07F5/02; G01N21/64; G01N33/53
Foreign References:
US20110287473A12011-11-24
Attorney, Agent or Firm:
PHARMA CONCEPTS GMBH (CH)
Download PDF: